@6thgradeleveltutorials
1 post audited · 6 claims analysed
Science evidence grade
Based on 6 claims across 1 audit
2
Supported
33%
1
Overstated
17%
0
Misleading
0%
3
No Evidence
50%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @6thgradeleveltutorials claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
33%
2 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
67%
4 claims
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(1 post)
“MOTS C Explained in 60 Seconds | Simple Breakdown #sports #science #brain”
The creator's claims about 'Matsi' cannot be verified because no peer-reviewed literature, clinical trials, or PubMed records exist for a peptide by that name. However, if 'Matsi' refers to MOTS-c (Mitochondrial-derived Oligopeptide that Enhances Stress Resistance-C), the metabolic and insulin-response claims are directionally supported by an active Phase 2a human clinical trial (NCT07505745) currently recruiting participants with prediabetes and overweight/obesity. The claim about improved endurance, blood sugar, and energy efficiency is supported in direction but overstated in certainty—the trial is ongoing and published human efficacy data is not yet available. All other claims (stress resilience, fat oxidation, AMPK activation) lack published evidence. Immediate clarification on the peptide's actual identity and the basis for the 'Matsi' nomenclature would be necessary for a complete evaluation.
Audit another post from @6thgradeleveltutorials
Paste their social post link to add a new audit